Protein sequencing is a process of determining the sequence of amino acid residues that make up a protein. It plays a key role in Proteomics which deals with large-scale study of protein structures. Protein sequencing finds applications in various sectors including biomedical research, pharmaceuticals, forensic science, microbiology, and food analysis. Key tools used in protein sequencing are mass spectrometry and Edman degradation.
The Protein Sequencing Market size is expected to reach US$ 4.22 billion by 2030, from US$ 1.90 billion in 2023, at a CAGR of 12.1% during the forecast period. Protein sequencing is the process of determining the amino acid sequence of a protein
Key Takeaways
Key players operating in the protein sequencing market are Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Shimadzu Corporation, Bio-Rad Laboratories, Bruker Corporation, JEOL Ltd., and SGS S.A. Growing R&D spending in proteomics, increasing prevalence of chronic diseases, and rising focus on personalized medicine are fueling the demand for protein sequencing solutions globally. Technological advancements in mass spectrometry techniques such as MALDI-TOF and liquid chromatography have enhanced protein identification and characterization capabilities, thus supporting market growth.
Market Trends
The market is witnessing a trend of integration of artificial intelligence and machine learning tools with Protein Sequencing Market Growth platforms. This is helping researchers analyze large proteomics datasets efficiently. Another key trend is the development of microfluidic chips and miniature mass spectrometers for portable point-of-care protein sequencing applications.
Market Opportunities
Growing application of protein sequencing in precision medicine presents significant opportunities. Efforts are ongoing to map human proteomes which could revolutionize treatment and diagnosis of diseases. Developing economies such as India, China, and Brazil are expected to offer lucrative opportunities for market players due to increasing healthcare investments and infrastructure development. Partnerships with pharmaceutical companies and research institutes will further boost their presence in emerging markets.
Impact of COVID-19 on Protein Sequencing Market Growth
The COVID-19 pandemic has significantly impacted the protein sequencing market growth. During the initial phases of the pandemic, various lockdowns and restrictions imposed supply chain disruptions. This led to shortages of raw materials and interrupted production activities. With research laboratories operating at limited capacities, the demand for protein sequencing products declined significantly. However, as the pandemic progressed, proteomics research focused extensively on understanding the novel coronavirus at molecular level. This drive the need for advanced protein sequencing technologies among research organizations.
Various government and private sector initiatives are underway to leverage advances in proteomics and protein sequencing. This will aid vaccine and therapeutic development for COVID-19. With lockdowns being gradually lifted, market players are resuming operations while maintaining safety protocols. The increased R&D focus on pandemics is expected to boost investments in this field. Various funding programs aim at enhancing genomic and proteomic infrastructure to strengthen pandemic preparedness.
Concentration of Protein Sequencing Market in Key Geographical Regions
North America dominates the global protein sequencing market in terms of value. Advanced research infrastructure and increasing investments in proteomics drive early adoption of protein sequencing technologies. Presence of leading market players and availability of skilled professionals support market growth. Asia Pacific is poised to be the fastest growing regional market during the forecast period. Rising research excellence in countries like China, India, and South Korea is expanding the customer base. Increasing healthcare expenditures, growing biotech industry and presence of low-cost manufacturing boost regional market prospects. Europe remains a major revenue generator supported by significant government grants for life science research.
Fastest Growing Regional Market
Asia Pacific market is poised to expand at the fastest pace among all geographical regions. Presence of prominent emerging economies, increasing R&D investments and expanding biopharmaceutical industry are major growth drivers. Growing awareness regarding applications of proteomics, presence of evolving life science clusters and liberal foreign investment policies support high growth potential. Rising government focus on biotechnology and investments in healthcare infrastructure further strengthen regional market position. Availability of low-cost skilled resources aids in cost-effective manufacturing and testing operations. With economic stability and developing research ecosystem, Asia Pacific is expected to witness tremendous growth opportunities in the protein sequencing industry over the coming years.
Get More Insights On- Protein Sequencing Market
Get This Report In Japanese Language
Get This Report In Korean Language
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)